Ethical dilemma in organ allocation for lung transplantation John-David Aubert Respiratory Division Lausanne-Geneva Lung Tx Centre - Switzerland ERS Vienna.

Slides:



Advertisements
Similar presentations
LUNG ALLOCATION SCORE SYSTEM UPDATE
Advertisements

The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.
The National Council on Economic Education/John Templeton Foundation Teaching the Ethical Foundations of Economics Lesson 7: Should We Allow a Market For.
CURRENT STATE OF LIVER ALLOCATION AND DISTRIBUTION John R. Lake, MD University of Minnesota Medical School.
Unit G: Organ Transplants. Basic facts related to organ transplants A.No age limits – under 18 requires parent or guardian consent A.No age limits – under.
Analysing GPs' ‘Mental Clusters’ in patients with dizziness U.-M. Schmidt, M. Gulich Department of General Practice, University of Ulm, Germany WONCA Europe,
THE PATIENT’S JOURNEY TO TRANSPLANT AND BEYOND
UNOS Region 8 MELD29 Trial Analysis of the Results
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Evaluating Diagnostic Accuracy of Prostate Cancer Using Bayesian Analysis Part of an Undergraduate Research course Chantal D. Larose.
Ethics and Organ Transplantation Divya Bappanad March 23, 2010.
Consideration of Net Benefit as applied to Organ Transplantation Workgroup 3 – UNOS Strategic Planning Retreat, Boston 10/05.
Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult ISKANDER AL-GITHMI, M.D., FRCSC, FRCSC (Ts & CDs), FCCP. Assistant Professor.
Tackling geographic disparity – Redistribution of livers Ryutaro Hirose, MD Professor, Surgery Vice Chair, UNOS Liver Intestine committee Region 5 Collaborative.
The Deceased Donor Kidney Allocation System
Tasks and responsibilities of the German organ procurement organization DSO Technical Assistance for Alignment in Organ Donation 1st International Symposium.
The Recipient Experience Jaime Myers, RN, MSN, CCTC April 29, 2011.
TRANSPLANTATION TODAY LILLY BARBA, M.D. MEDICAL DIRECTOR RENAL TRANSPLANT PROGRAM HARBOR-UCLA MEDICAL CENTER APRIL 12, 2010.
Moving up to Secondary School in September 2016 Important information, significant dates and useful contacts. Customer Services.
Table SA-1: Number of Kidney Transplants by Donor Type and Re-Transplant Status Source: Canadian Organ Replacement Register, 2014, CIHI *Missing data for.
ORGAN TRANSPLANTS Basic Facts and Organizations that Support Organ Transplantation.
ORGAN DONATION By: Aubree Malone. “When you’re not an organ donor when you die, you’re taking a lot of people with you.”
An International Case Study of Lung Transplantation
Multiple Choice Questions for discussion
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Eurotransplant: An example of success for cross-border cooperation Bruno Meiser Eurotransplant International Foundation, Leiden, Netherlands Dept. of Cardiac.
EPIB-591 Screening Jean-François Boivin 29 September
Lung Transplantation Guidelines For Selection Milpark Hospital Transplant Unit Johannesburg, South Africa SATS Controversies Meeting May 2011.
Organ donation Peter Bishop Clinical lead for organ donation.
Stephen Cole SICSAG September 2009 “making donation usual, not unusual”
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
實習生 : 中山醫 李佳靜 指導老師 : 陳燕慈 營養師 The Relationship of BMI and Lung Transplant Recipients 1.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
Organ Allocation Heather Lindner-Thornton RN, MSN, CPTC Organ Procurement Coordinator.
Liver and Intestinal Organ Transplantation Committee Update Report David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Ethics and Policy Conference Day One Summary. Goals of the Meeting Educate people about the status of various protocol decisions Define areas where we.
OPTN Proposal to Revise the Lung Allocation Score (LAS) System and Salient Activities of the Thoracic Organ Transplantation Committee.
Ethical issues in selection of research subjects Bernard Lo, M.D. July 28, 2001.
Title of presentation Implementing DCD Barriers and solutions VPNG 51 st State Conference 30 th July 2015 Nicky Stitt Donation Specialist Nursing Coordinator.
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM
1 Proposal to Modify Pediatric Lung Allocation Policy Thoracic Organ Transplantation Committee Fall 2015.
OFEV ® (nintedanib) TOMORROW trial results Last updated These slides are provided by Boehringer Ingelheim for medical to medical education only.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
When Using SRTR Slides. SRTR Slide Use Guidelines.
Organ Transplantation. Why is Organ Donation So Important?  There are around 1600 people currently waiting for a transplant in Australia  In 2012, 354.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
BTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults British Thoracic Society Intensive Care Society.
Draft Organ Allocation Criteria. Factors affecting Allocation Medical need Length of waiting time: time a illness progressed to a point when transplant.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL R2 이윤정 Richard A. Belkin, Noreen R. Henig, Lianne G. Singer, Cecilia Chaparro,
Cadaveric vs Living Donation; Comparing Options
Kidney transplantations in the Slovak republic, Hungary, and Austria
11/11/16 Kirstie Wallace/Hazel Muse Transplant Co-ordinators
Heather Lindner-Thornton RN, MSN, CPTC Organ Procurement Coordinator
The Recipient Experience
HCV & liver transplantation
Organ, Eye and Tissue Donation in New York
What Patients Should Know About the New Adult Heart Allocation System
Liver Transplant For Patients with PSC
Thoracic Organ Transplantation Committee Spring 2014
What Patients Should Know About the New Adult Heart Allocation System
Thoracic Organ Transplantation Committee Spring 2019
Ethical Implications of Multi-Organ Transplants (MOT)
Proposal to Delay the HCC Exception Score Assignment
Identifying Low-Risk Patients with Pulmonary Embolism Suitable For Outpatient Treatment A VERITY Registry Pilot Study N Scriven, T Farren, S Bacon, T.
Donor Allocation Policy in the US
Presentation transcript:

Ethical dilemma in organ allocation for lung transplantation John-David Aubert Respiratory Division Lausanne-Geneva Lung Tx Centre - Switzerland ERS Vienna 2012

Disclosure - JD Aubert Financial support for travel from: Astellas Boehringer Ingelheim

Organ procurement from deceased donors Why is it different from other therapies ? A treatment strategy with an explicit shortage of organs Unpredictable waiting time from the therapeutic decision (listing) to the effective therapy (transplantation)  anticipation

Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Situation # 1 Recipient 1 63 yr COPD Ex-smoker Intubated in the ICU since 10 days Waiting time : 30 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 230 days

Your choice ? Recipient 1 63 yr COPD ? Recipient 2 35 yr Cystic Fibrosis ? 12

Analysis of determinant criteria If you choose 1 the 63 yr COPD: Risk of death for the recipient 1 > Risk for the Recipient 2  Medical efficacy If you choose 2 the 35 yr CF: Younger age Age match with the donor CF is not a self-inflicted disease such as smoke-induced COPD  Equity

Conflicting Principles in Organ Transplantation Medical Efficacy Equity

LET US CHANGE JUST TWO ITEMS….

Donor: 64 yr, death through brain injury, ex smoker, PaO2 = 410 mmHg Situation # 1 bis Recipient 1 63 yr COPD Ex-smoker Intubated in the ICU since 10 days Waiting time : 30 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 230 days

Your choice ? (1bis) 1.Transplant the 63 yr COPD 2.Transplant the 35 yr CF 3.Do not accept these lungs

WHO statement (GP 9, May 2010) Organ allocation must be Open Transparent Fair Equitable

Council of Europe: Statute art 15b Organ transplantation should follow the rules: 1.An allocation system should exist 2.Management of the official waiting list 3.Organs should be allocated to officially registered recipients 4.Criteria for registration on the list should be explicit 5.A patient can be registred on only one list 6.Transplant centres should be certified 7.The management of the list and the organ allocation should be controlled at the national level

The ways to allocate organ from deceased donors Random selection Through the economic rules of supply and demand Centre-based through expert opinion of the surgeon By chronological order +/- established exceptions By a severity score of the recipients

The ways to allocate organ from deceased donors Random selection Through the economic rules of supply and demand Centre-based through expert opinion of the surgeon By chronological order +/- established exceptions By a severity score of the recipients

Allocation through the transplant surgeon and/or the transplant pneumologist Pro Decision in expert hands Flexibility in particular cases Optimal match donor- recipient Con Criteria are not open Potential bias Detailed knowledge of each recipient’s history? Cognitive performance 24h a day?

Putative criteria used by the transplant surgeon Priority to the sickest patient Size match between donor and recipient Age difference between donor and recipient > 30 years Extra caution when a TX had turned bad in the previous month!...

 Allocation through the surgeon

Expert surgeon Back to Situation # 1 Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Recipient 1 63 yr COPD Ex-smoker Intubated in the ICU since 10 days Waiting time : 30 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 230 days

Chronological order with priorities First come – First served Priority = urgent cases (ICU) IPF, PAH… The allocation is patient-based and no longer centre-based

 Allocation through the surgeon  Centralized patient allocation, with queuing

Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Situation # 2 Recipient 1 53 yr IPF 1st LTX 2007  BOS Listed for redo Under non-invasive ventilation 16/24h Waiting time : 230 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 60 days

Your choice ? (2) 1.Re-Transplant the 53 yr recipient 2.Transplant the 35 yr CF 3.Transplant the 35 yr CF and remove the 53 yr recipient from the waiting list

Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Situation # 2 Recipient 1 53 yr IPF 1st LTX 2007  BOS Listed for redo Under non-invasive ventilation 16/24h Waiting time : 230 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 60 days

Redo LTX: usual practice Same priority as first LTX Some programs do not consider urgent status for Redo recipients (e.g. France)

LAS Calculator The Lung Allocation Score (LAS) is a numerical calculation used for allocating lungs to candidates who are 12 years of age or older. The LAS is calculated from clinical diagnostic factors which estimate each candidate's waitlist urgency and post-transplant survival probability Lung allocation score LAS - USA

Is it possible to predict, before transplantation, the survival after LTX?

Predictive ROC curve for specific preTX diagnosis DiagnosisCOPDIPFCF AUC AUC = 0.5  Random AUC = 1.0  Perfect prediction

THE LUNG ALLOCATION SCORE IS MORE PREDICTIVE FOR THE WAITING LIST MORTALITY THAN THE POST TX SURVIVAL An understatement…..

 Allocation through the surgeon  Centralized patient allocation, with queuing  Lung allocation severity score

Expert surgeon Centralized allocation + urgency criteria LAS Back to Situation # 1 Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Recipient 1 63 yr COPD Ex-smoker Intubated in the ICU since 10 days Waiting time : 30 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 230 days

Donor: 36 yr, death through brain injury, non smoker, PaO2 = 410 mmHg Back to situation # 2 Recipient 1 53 yr IPF 1st LTX 2007  BOS Listed for redo Under non-invasive ventilation 16/24h Waiting time : 230 days Recipient 2 35 yr Cystic Fibrosis At home on Oxygen + nutrition by PEG > 6 exacerbations the last year Waiting time : 60 days LAS= 50.65LAS = 40.20

How to compare different allocation systems ? Number of lung TX/ Mio habitants ? Median waiting time on the list ? Mortality on the waiting list ? Acceptance rate of organs ? Survival 1,3, 5 years after lung TX ?

Would you transplant « Joe the ugly » ? A 49 yr prisoner, with rapidly progressing IPF. Jailed with life- sentence for numerous crimes and murders

Your choice case # 3 1.This prisoner should be put on the waiting list 2.This prisoner should not be offered a lung transplant 3.Unsure

Shocking: Doctors have given new lungs to Joe the Ugly! If you answered yes, Have you thought on the impact on organ donation to this type of recipient in the general population ?

My choice: Do not list Joe the Ugly for lung TX The reason: he did not quit smoking….

To conclude Organ transplantation = therapy with explicit shortage of supply Equity and medical efficacy are the two (sometimes) antagonistic forces that drive the process Different allocation systems coexist within Europe Comparison of distinct allocation systems should not be based on a single parameter